Annika Auranen
Tampere, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Comprehensive cancer care in the Nordic countries; Strengths, opportunities and improvement profiles.
Journal: Journal of cancer policy
Published: January 31, 2026
Changing Practices of Opportunistic Salpingectomies and Oophorectomies From 1997 to 2017: A Nationwide Study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: May 24, 2025
Implementation of extensive cytoreductive surgery protocol in advanced epithelial ovarian cancer: Real-world data on surgical treatment distribution and survival of the whole patient cohort; a single center experience.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: January 05, 2025
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in arm A of the NSGO-OV-UMB1/ENGOT-OV30 trial.
Journal: Molecular oncology
Published: January 02, 2025
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer.
Journal: Gynecologic oncology
Published: November 14, 2024
Erratum: Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers.
Journal: Applied clinical informatics
Published: November 04, 2024
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers.
Journal: Applied clinical informatics
Published: September 11, 2024
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial.
Journal: Gynecologic oncology
Published: September 11, 2024
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer".
Journal: Future oncology (London, England)
Published: July 11, 2024
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 01, 2024
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
Journal: Therapeutic advances in medical oncology
Published: May 21, 2024
NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer.
Journal: Gynecologic oncology
Published: May 05, 2024
Last Updated: 09/26/2026